Hematopoietic Stem Cell Transplantation Market Analysis and Forecast 2023 to 2033
The global hematopoietic stem cell transplantation market had a market value of US$ 7 billion in 2023 and is expected to reach a market value of US$ 15 billion by 2033, growing at an 8% CAGR from 2023 to 2033. The global hematopoietic stem cell transplantation industry is expected to grow significantly over the forecast period due to the increasing prevalence of leukaemia and lymphoma. Every year, more than 2000 cord blood hematopoietic stem cell transplants are performed, according to the World Health Organization (WHO) (WHO). Bone marrow and blood contain hematopoietic stem cells (HSCs). Hematopoietic progenitor cells are another name for them (HPCs). Hematopoietic stem cells can produce platelets, white blood cells, and red blood cells, among other blood types. These cells are used to rebuild or replace a patient's hematopoietic system in the treatment of both malignant (such as lymphoma and leukaemia) and non-malignant (such as bone marrow failure and hemoglobinopathies). ...